Probiotic Supplement as Treatment for Students With ADHD

Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial

Official title: A Double-Blind Placebo Controlled Study of Probiotic Supplement as Treatment for Students With Attention Deficit Hyperactivity Disorder (ADHD)

Status Active, not recruiting

Clinical Trial Summary

Subjects will answer the following questionnaire and tests:

• Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)

• Demographic Questionnaire - composed by the researchers

• Family Eating Habits Questionnaire (FEAHQ-33)

• Food Frequency Questionnaire (FFQ)

• Test MOXO

The subjects will take the study product for six months.

After six months the subject will fill once again all the questionnaires.

Clinical Trial Description

Computerized performance test MOXO - the test has been developed in Israel by Neurotech Company. The test's goal is to assess and define a participant's performance according to the four indices of Attention Deficit Hyperactivity Disorder: Attention, Hyperactivity, Impulsivity, and Timing with adjustment for age.

Subjects will answer the following questionnaire and tests:

• Symptom severity and improvement will be measured using ADHA Rating scale IV (ADHD RS)

• Demographic Questionnaire - composed by the researchers

• Family Eating Habits Questionnaire (FEAHQ-33)

• Food Frequency Questionnaire (FFQ)

• Test MOXO

The subjects will take the study product for six months.

After six months the subject will fill once again all the questionnaires. ;

Related Conditions & MeSH terms

• Attention Deficit Disorder with Hyperactivity
• Attention Deficit Hyperactivity Disorder (ADHD)
• Hyperkinesis

• NCT number: NCT02908802
• Study type: Interventional
• Source: Tel Hai College
• Status: Active, not recruiting
• Phase: N/A
• Start date: November 2016
• Completion date: October 2019